Pathogenesis of Pancreatic Cancer-related Diabetes Mellitus: Quo Vadis?
| dc.contributor.author | Korc, Murray | |
| dc.contributor.department | Medicine, School of Medicine | en_US |
| dc.date.accessioned | 2020-07-30T11:06:32Z | |
| dc.date.available | 2020-07-30T11:06:32Z | |
| dc.date.issued | 2019-05 | |
| dc.eprint.version | Author's manuscript | en_US |
| dc.identifier.citation | Korc M. (2019). Pathogenesis of Pancreatic Cancer-Related Diabetes Mellitus: Quo Vadis?. Pancreas, 48(5), 594–597. https://doi.org/10.1097/MPA.0000000000001300 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/23428 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Wolters Kluwer | en_US |
| dc.relation.isversionof | 10.1097/MPA.0000000000001300 | en_US |
| dc.relation.journal | Pancreas | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | PMC | en_US |
| dc.subject | Pancreatitis | en_US |
| dc.subject | Pancreatic cancer associated diabetes | en_US |
| dc.subject | Pancreatic ductal adenocarcinoma | en_US |
| dc.subject | T2DM | en_US |
| dc.subject | Beta cell failure | en_US |
| dc.subject | Hyperglycemia | en_US |
| dc.subject | Obesity | en_US |
| dc.subject | T1DM | en_US |
| dc.subject | NoD | en_US |
| dc.subject | Early diagnosis | en_US |
| dc.subject | Prevention strategies | en_US |
| dc.subject | Population susceptibilities | en_US |
| dc.subject | Combinatorial therapeutic modalities | en_US |
| dc.title | Pathogenesis of Pancreatic Cancer-related Diabetes Mellitus: Quo Vadis? | en_US |
| dc.type | Article | en_US |